GetTopicDetailResponse(id=b4d31111274, topicName=Lusutrombopag, introduction=Lusutrombopag, content=null, image=null, comments=3, allHits=1037, url=https://h5.medsci.cn/topic?id=11112, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=86332, tagList=[TagDto(tagId=86332, tagName=Lusutrombopag)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=2003289, encodeId=4520200328949, content=<a href='/topic/show?id=b4d31111274' target=_blank style='color:#2F92EE;'>#Lusutrombopag#</a>, objectTitle=Shionogi宣布在英國(guó)推出血小板生成素受體激動(dòng)劑Mulpleo（lusutrombopag），用于接受侵入性治療的慢性肝病成年患者的嚴(yán)重血小板減少癥, objectType=article, longId=189673, objectId=433d1896e3eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=433d1896e3eb, replyNumber=0, likeNumber=0, createdTime=2020-10-12, rootId=0, userName=andy2087, userId=d275294, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=433d1896e3eb, moduleTitle=Shionogi宣布在英國(guó)推出血小板生成素受體激動(dòng)劑Mulpleo（lusutrombopag），用于接受侵入性治療的慢性肝病成年患者的嚴(yán)重血小板減少癥, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=433d1896e3eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2003287, encodeId=d6fb200328e54, content=<a href='/topic/show?id=b4d31111274' target=_blank style='color:#2F92EE;'>#Lusutrombopag#</a>, objectTitle=J Gastroenterology：lusutrombopag可在慢性肝病射頻消融術(shù)中增加血小板的數(shù)量, objectType=article, longId=159751, objectId=c49b159e5168, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c49b159e5168, replyNumber=0, likeNumber=98, createdTime=2020-01-14, rootId=0, userName=andy2087, userId=d275294, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c49b159e5168, moduleTitle=J Gastroenterology：lusutrombopag可在慢性肝病射頻消融術(shù)中增加血小板的數(shù)量, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=c49b159e5168)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2003288, encodeId=65c92003288a3, content=<a href='/topic/show?id=b4d31111274' target=_blank style='color:#2F92EE;'>#Lusutrombopag#</a>, objectTitle=歐盟批準(zhǔn)Lusutrombopag用于治療嚴(yán)重血小板減少癥, objectType=article, longId=161323, objectId=b01d161323bc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b01d161323bc, replyNumber=0, likeNumber=89, createdTime=2019-07-12, rootId=0, userName=andy2087, userId=d275294, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b01d161323bc, moduleTitle=歐盟批準(zhǔn)Lusutrombopag用于治療嚴(yán)重血小板減少癥, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=b01d161323bc)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
